![Russell Cox](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Cox
Directeur/Membre du Conseil chez
GOSSAMER BIO, INC.
Fortune : 1 188 $ au 30/06/2026
Profil
Russell J.
Cox is Executive Chairman at Epirium Bio, Inc. since 2025.
Mr. Cox is Director at Vascular Cures since 2013.
Mr. Cox is Independent Director at Gossamer Bio, Inc. since 2018.
Formerly, Mr. Cox was Chief Executive Officer & Director at Vital Therapies, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Co-Chief Executive Officer & Director at Immunic, Inc. from 2018 to 2019.
Formerly, Mr. Cox was Chairman at Spyre Therapeutics, Inc. from 2019 to 2024.
Formerly, Mr. Cox was Group Product Manager at Genentech, Inc. from 1987 to 1999.
Formerly, Mr. Cox was Vice President-Marketing at Scios, Inc. from 2003 to 2007.
Formerly, Mr. Cox was Vice President-Marketing at Tercica, Inc. from 2007 to 2008.
Formerly, Mr. Cox was Chief Commercial Officer & EVP at Jazz Pharmaceuticals, Inc. in 2013.
Formerly, Mr. Cox was Chief Commercial Officer & Senior Vice President at Ipsen, Inc. from 2009 to 2010.
Formerly, Mr. Cox was Chief Operating Officer & Executive Vice President at Jazz Pharmaceuticals Plc from 2014 to 2018.
Mr. Cox completed undergraduate education at Texas A&M University in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 7 200 ( 0 % ) | 1 188 $ | 30/06/2026 |
Postes actifs de Russell Cox
| Sociétés | Poste | Début |
|---|---|---|
| GOSSAMER BIO, INC. | Directeur/Membre du Conseil | 19/12/2018 |
Vascular Cures
 Vascular Cures Miscellaneous Commercial ServicesCommercial Services Operates as voluntary health organization | Directeur/Membre du Conseil | 01/01/2013 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Président | 01/01/2025 |
Anciens postes connus de Russell Cox
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Président | 13/05/2024 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Directeur Général | 25/01/2019 |
| IMMUNIC, INC. | Directeur Général | 01/01/2019 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Directeur des opérations | 03/01/2018 |
| JAZZ PHARMACEUTICALS PLC | Directeur des opérations | 03/01/2018 |
Formation de Russell Cox
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Manufactures thermal processing equipment and systems | Producer Manufacturing |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Vascular Cures
Vascular Cures Miscellaneous Commercial ServicesCommercial Services Operates as voluntary health organization | Commercial Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Choisissez Zonebourse 
